Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Targeting bystander protein improves sepsis outcome

April 20, 2020

Topoisomerase 2-beta knockdown yields model of diastolic dysfunction

April 15, 2020

Galectin-3 predicts prognosis in sudden cardiac arrest in out-of-hospital patients

April 15, 2020

Exosomes deliver sepsis treatment

April 14, 2020

Cardurion Pharmaceuticals presents CAMK2 inhibitors

April 9, 2020

Novel diet-induced obese rat model of AF

April 6, 2020

Sepsis study may yield new treatment strategies

March 30, 2020

Milestone reports phase III topline data on at-home use of etripamil for PSVT

March 24, 2020

New MAb increases the effects of PF4 in sepsis, stabilizing NETs and enhancing microbial entrapment

March 24, 2020

Positive final data from phase Ib study of Allocetra-OTS in severe sepsis

March 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...